Download the DIA Global Meeting App
The DIA has an app to help navigate meetings from your smart device, and has been updated this year.
The DIA has an app to help navigate meetings from your smart device, and has been updated this year. To get the free app, search "DIA Global" in your device's app store and login to the app with the email you use for DIA Events registration. By selecting "reset password" you can get a new password emailed to you. Once in the app, go to the meeting you want found under the Events icon. The new app features
- Activity Stream that provides real-time updates
- Manage your meeting agenda
- Connect and network with meeting attendees
- Interactive floor plans
- View exhibiting companies with their booth numbers
- Earn points and badges for activity within the app, tallied within the Leaderboard
- Integration with your social media channels
DIA encourages attendees to download the app prior to the meeting so as to enjoy the full benefits of the app and to avoid delays during the download process.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
